» Articles » PMID: 20610351

Health-related Quality of Life in Hypertension, Chronic Kidney Disease, and Coexistent Chronic Health Conditions

Overview
Specialty Nephrology
Date 2010 Jul 9
PMID 20610351
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

With the increasing prevalence of hypertension, there has been a growing interest in understanding the health-related quality of life (HRQOL) of patients with hypertension. Although hypertension is often perceived as asymptomatic, it is associated with impaired HRQOL because of complications or comorbidities, awareness of the diagnosis, and adverse effects from antihypertensive medications. This article focuses on the literature published since 2000, on HRQOL in elderly hypertensive individuals as well as hypertensives with co-existent diseases, including chronic kidney disease, cardiovascular disease, and diabetes mellitus. Most of the studies found that hypertensive individuals with co-existent co-morbidities tend to have lower HRQOL than those with hypertension alone, and identified the number of co-morbid illnesses as an independent determinant of HRQOL. The most pronounced effect was noted in the physical function domains of HRQOL. Studies have also examined the effects on HRQOL of specific classes of antihypertensive drugs without specific demonstration of superiority of one drug class over another in terms of HRQOL measures. Although there is evidence in favor of angiotensin-converting enzyme-inhibition for improving renal and cardiovascular outcomes in hypertensive patients, its role in ameliorating HRQOL outcomes remains to be established.

Citing Articles

Impaired glomerular filtration rate and associated factors among diabetic mellitus patients with hypertension in referral hospitals, Amhara Regional State, Ethiopia.

Gela Y, Belay D, Belsti Y, Getahun A, Getnet M, Bitew D Sci Rep. 2024; 14(1):25143.

PMID: 39448700 PMC: 11502774. DOI: 10.1038/s41598-024-77318-5.


Hypertension, depression, and health-related quality of life among hospitalized patients in Afghanistan.

Neyazi A, Mohammadi A, Neyazi M, Timilsina S, Padhi B, Griffiths M J Hum Hypertens. 2024; 38(6):529-537.

PMID: 38684866 DOI: 10.1038/s41371-024-00914-5.


Health-Related Quality of Life in Sudanese Children with Nephrotic Syndrome: A Comparative Cross-Sectional Study.

Naim F, Bakhiet Y, Mohmmedahmed M, Yousef B Pediatric Health Med Ther. 2024; 15:133-144.

PMID: 38563042 PMC: 10984192. DOI: 10.2147/PHMT.S437364.


Association between health-related quality of life and nonadherence to antihypertensive medication.

Kim K Nurs Open. 2023; 10(6):3570-3578.

PMID: 36598870 PMC: 10170916. DOI: 10.1002/nop2.1599.


Factors Influencing Self-Care Behaviors in Hypertension Patients With Complications.

Pahria T, Nugroho C, Yani D Vasc Health Risk Manag. 2022; 18:463-471.

PMID: 35818584 PMC: 9270883. DOI: 10.2147/VHRM.S366811.


References
1.
Agewall S, Wikstrand J, Dahlof C, Fagerberg B . Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk. Am J Hypertens. 1996; 9(6):545-50. DOI: 10.1016/0895-7061(95)00355-x. View

2.
Bulpitt C, Connor M, Schulte M, Fletcher A . Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life. J Hum Hypertens. 2000; 14(3):205-12. DOI: 10.1038/sj.jhh.1000972. View

3.
. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 1997; 349(9069):1857-63. View

4.
McCullough P, Soman S, Shah S, Smith S, Marks K, Yee J . Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000; 36(3):679-84. DOI: 10.1016/s0735-1097(00)00774-9. View

5.
Maschio G, Alberti D, Janin G, Locatelli F, Mann J, Motolese M . Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med. 1996; 334(15):939-45. DOI: 10.1056/NEJM199604113341502. View